A well being employee shows vials of COVID-19 vaccines in Guwahati.
As the demand for COVID-19 vaccines rises globally, India on Thursday stated it might not be right to talk about the supply of jabs to different international locations for the time being as it’s at present ramping up home manufacturing for its personal inoculation programme.
Elaborating the steps taken by the federal government to increase vaccine supply for home use, Ministry of External Affairs (MEA) Spokesperson Arindam Bagchi stated India stays engaged with US vaccine producers like Pfizer, Johnson & Johnson, and Moderna as a part of this effort.
“I just responded to a series of questions on what steps the government has taken to ensure adequate supply of vaccines from abroad. I think you will appreciate that against this background, it would not be right to talk about supply of vaccines abroad just now as we have repeatedly conveyed,” he stated.
“We are currently purposing domestic vaccine production for our own vaccination programme,” Bagchi.
After it began its personal inoculation programme in January, India additionally provided vaccine to different international locations. In response to a query in Lok Sabha on March 23, Minister of State for External Affairs V Muraleedharan stated India has provided 600 million doses to 76 international locations underneath the ‘Vaccine-Maitri’ initiative.
ALSO READ |Â Biden publicizes world vaccine sharing program, plans to ship extra doses to India, different affected nations
Â
Of the 600 million doses, round 341 million doses had been provided on industrial foundation, whereas round 177 doses had been provided to GAVI’s COVAX.
The remaining 81 million had been provided as grant.
However, it got here to a halt after the lethal second wave of the coronavirus hit the nation, killing hundreds. The authorities additionally obtained flak for exporting jabs. The vaccine export ban by India has led to a scarcity in different international locations. The authorities has been in talks with the US over the scarcity of vaccines within the nation.
“We are also engaged with the US Administration to ensure that necessary components and raw materials for vaccine production in India are readily available. This issue was taken up most recently during External Affairs Minister S Jaishankar’s visit to the USA. It is in our mutual interest to combat the global pandemic by expediting vaccination efforts,” he stated.
Sharing particulars about Jaishankar’s go to to the US final month, Bagchi stated the minister’s programme included conferences with the US management, interactions with the members of the Congress, CEOs of the US firms and assume tanks.
“Discussions had been extensive ranging and encompassed India-US bilateral relations, cooperation on regional and world points such because the Indo-Pacific area, the Quad dialogue, Afghanistan, Myanmar and the UNSC to title a number of.
“Both sides focused on the ongoing efforts to combat COVID-19, expeditious vaccination, enhancing access to vaccines, ensuring smooth and open supply chains for vaccines and related materials and securing of waiver under TRIPS (Trade-Related Aspects of Intellectual Property Rights) for COVID-19 vaccines,” Bagchi added.
ALSO READ |Â US Vice President Kamala Harris dials PM Modi, assures supply of Covid vaccine underneath world sharing plan
Â
